These findings also justify a deeper investigation into its role in modulating inflammasome activation, especially in diseases like Alzheimer’s and diabetes, where NLRP3 and oxidative stress play central roles (Qin et al., 2024; Alqahtani et al., 2023). The gene discussed is NLRP3; the disease is diabetes mellitus.